Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease
We examine the potential mechanisms by which the addition of either quinapril or irbesartan can regulate vascular function in patients already on a regimen of aspirin and atorvastatin therapy.
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2003-05, Vol.91 (9), p.1116-1119 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1119 |
|---|---|
| container_issue | 9 |
| container_start_page | 1116 |
| container_title | The American journal of cardiology |
| container_volume | 91 |
| creator | Lauten, Wright B Khan, Qamar A Rajagopalan, Sanjay Lerakis, Stamatios Rahman, Syed T Parthasarathy, Sampath Khan, Bobby V |
| description | We examine the potential mechanisms by which the addition of either quinapril or irbesartan can regulate vascular function in patients already on a regimen of aspirin and atorvastatin therapy. |
| doi_str_mv | 10.1016/S0002-9149(03)00161-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73221613</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914903001619</els_id><sourcerecordid>341843521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-997db5bd89535851694adf348dc1e7710ac8ab94ea677b7083a40f586d1620b13</originalsourceid><addsrcrecordid>eNqFUU2L1TAUDaI4z9GfoAQXootqbtM2zWqQwS8YcKGzDmlzy8vQJm9y0yf-D3-weR8ouBECSW7OOTf3HMaeg3gLArp334QQdaWh0a-FfCNKCSr9gG2gV7oCDfIh2_yBXLAnRHflCtB2j9kF1AoaaPWG_bolnNY5IBGPE79ffbC75Gdug-M-DUg2ZRt4jtwvuxT3yPMWy2v2lQ_TbJfF5ph-8oS0i4HwoHKo7C1lm304Clna-VTOZe1KEUMm_sPnLR9jisEW-hZLH-48oSV8yh5NdiZ8dt4v2e3HD9-vP1c3Xz99uX5_U42y73OltXJDO7het7LtW-h0Y90km96NgEqBsGNvB92g7ZQalOilbcTU9p2DrhYDyEv26qRbBrtfkbJZPI04zzZgXMkoWdfFV1mAL_8B3sU1hfI3U0shFahaFVB7Ao0pEiWcTDFyKcMZEOaQmTlmZg6BGCHNMTOjC-_FWXwdFnR_WeeQCuDqBMDixd5jMjQWD0d0PuGYjYv-Py1-AwxZqPo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230371727</pqid></control><display><type>article</type><title>Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lauten, Wright B ; Khan, Qamar A ; Rajagopalan, Sanjay ; Lerakis, Stamatios ; Rahman, Syed T ; Parthasarathy, Sampath ; Khan, Bobby V</creator><creatorcontrib>Lauten, Wright B ; Khan, Qamar A ; Rajagopalan, Sanjay ; Lerakis, Stamatios ; Rahman, Syed T ; Parthasarathy, Sampath ; Khan, Bobby V</creatorcontrib><description>We examine the potential mechanisms by which the addition of either quinapril or irbesartan can regulate vascular function in patients already on a regimen of aspirin and atorvastatin therapy.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(03)00161-9</identifier><identifier>PMID: 12714159</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Anticholesteremic Agents - therapeutic use ; Aspirin ; Aspirin - therapeutic use ; Atorvastatin ; Biphenyl Compounds - therapeutic use ; Cardiovascular disease ; Cholesterol, LDL - blood ; Coronary Disease - drug therapy ; Coronary Disease - immunology ; Drug Therapy, Combination ; Female ; Heptanoic Acids - therapeutic use ; Humans ; Interleukin-6 - blood ; Irbesartan ; Isoquinolines - therapeutic use ; Male ; Middle Aged ; Monocytes - metabolism ; Patients ; Platelet Aggregation Inhibitors - therapeutic use ; Pyrroles - therapeutic use ; Quinapril ; Tetrahydroisoquinolines ; Tetrazoles - therapeutic use</subject><ispartof>The American journal of cardiology, 2003-05, Vol.91 (9), p.1116-1119</ispartof><rights>2003 Excerpta Medica Inc.</rights><rights>Copyright Elsevier Sequoia S.A. May 1, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-997db5bd89535851694adf348dc1e7710ac8ab94ea677b7083a40f586d1620b13</citedby><cites>FETCH-LOGICAL-c388t-997db5bd89535851694adf348dc1e7710ac8ab94ea677b7083a40f586d1620b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914903001619$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12714159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lauten, Wright B</creatorcontrib><creatorcontrib>Khan, Qamar A</creatorcontrib><creatorcontrib>Rajagopalan, Sanjay</creatorcontrib><creatorcontrib>Lerakis, Stamatios</creatorcontrib><creatorcontrib>Rahman, Syed T</creatorcontrib><creatorcontrib>Parthasarathy, Sampath</creatorcontrib><creatorcontrib>Khan, Bobby V</creatorcontrib><title>Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>We examine the potential mechanisms by which the addition of either quinapril or irbesartan can regulate vascular function in patients already on a regimen of aspirin and atorvastatin therapy.</description><subject>Angiotensin Receptor Antagonists</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Anticholesteremic Agents - therapeutic use</subject><subject>Aspirin</subject><subject>Aspirin - therapeutic use</subject><subject>Atorvastatin</subject><subject>Biphenyl Compounds - therapeutic use</subject><subject>Cardiovascular disease</subject><subject>Cholesterol, LDL - blood</subject><subject>Coronary Disease - drug therapy</subject><subject>Coronary Disease - immunology</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Heptanoic Acids - therapeutic use</subject><subject>Humans</subject><subject>Interleukin-6 - blood</subject><subject>Irbesartan</subject><subject>Isoquinolines - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Monocytes - metabolism</subject><subject>Patients</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Pyrroles - therapeutic use</subject><subject>Quinapril</subject><subject>Tetrahydroisoquinolines</subject><subject>Tetrazoles - therapeutic use</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUU2L1TAUDaI4z9GfoAQXootqbtM2zWqQwS8YcKGzDmlzy8vQJm9y0yf-D3-weR8ouBECSW7OOTf3HMaeg3gLArp334QQdaWh0a-FfCNKCSr9gG2gV7oCDfIh2_yBXLAnRHflCtB2j9kF1AoaaPWG_bolnNY5IBGPE79ffbC75Gdug-M-DUg2ZRt4jtwvuxT3yPMWy2v2lQ_TbJfF5ph-8oS0i4HwoHKo7C1lm304Clna-VTOZe1KEUMm_sPnLR9jisEW-hZLH-48oSV8yh5NdiZ8dt4v2e3HD9-vP1c3Xz99uX5_U42y73OltXJDO7het7LtW-h0Y90km96NgEqBsGNvB92g7ZQalOilbcTU9p2DrhYDyEv26qRbBrtfkbJZPI04zzZgXMkoWdfFV1mAL_8B3sU1hfI3U0shFahaFVB7Ao0pEiWcTDFyKcMZEOaQmTlmZg6BGCHNMTOjC-_FWXwdFnR_WeeQCuDqBMDixd5jMjQWD0d0PuGYjYv-Py1-AwxZqPo</recordid><startdate>20030501</startdate><enddate>20030501</enddate><creator>Lauten, Wright B</creator><creator>Khan, Qamar A</creator><creator>Rajagopalan, Sanjay</creator><creator>Lerakis, Stamatios</creator><creator>Rahman, Syed T</creator><creator>Parthasarathy, Sampath</creator><creator>Khan, Bobby V</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20030501</creationdate><title>Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease</title><author>Lauten, Wright B ; Khan, Qamar A ; Rajagopalan, Sanjay ; Lerakis, Stamatios ; Rahman, Syed T ; Parthasarathy, Sampath ; Khan, Bobby V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-997db5bd89535851694adf348dc1e7710ac8ab94ea677b7083a40f586d1620b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Angiotensin Receptor Antagonists</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Anticholesteremic Agents - therapeutic use</topic><topic>Aspirin</topic><topic>Aspirin - therapeutic use</topic><topic>Atorvastatin</topic><topic>Biphenyl Compounds - therapeutic use</topic><topic>Cardiovascular disease</topic><topic>Cholesterol, LDL - blood</topic><topic>Coronary Disease - drug therapy</topic><topic>Coronary Disease - immunology</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Heptanoic Acids - therapeutic use</topic><topic>Humans</topic><topic>Interleukin-6 - blood</topic><topic>Irbesartan</topic><topic>Isoquinolines - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Monocytes - metabolism</topic><topic>Patients</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Pyrroles - therapeutic use</topic><topic>Quinapril</topic><topic>Tetrahydroisoquinolines</topic><topic>Tetrazoles - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lauten, Wright B</creatorcontrib><creatorcontrib>Khan, Qamar A</creatorcontrib><creatorcontrib>Rajagopalan, Sanjay</creatorcontrib><creatorcontrib>Lerakis, Stamatios</creatorcontrib><creatorcontrib>Rahman, Syed T</creatorcontrib><creatorcontrib>Parthasarathy, Sampath</creatorcontrib><creatorcontrib>Khan, Bobby V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lauten, Wright B</au><au>Khan, Qamar A</au><au>Rajagopalan, Sanjay</au><au>Lerakis, Stamatios</au><au>Rahman, Syed T</au><au>Parthasarathy, Sampath</au><au>Khan, Bobby V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2003-05-01</date><risdate>2003</risdate><volume>91</volume><issue>9</issue><spage>1116</spage><epage>1119</epage><pages>1116-1119</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>We examine the potential mechanisms by which the addition of either quinapril or irbesartan can regulate vascular function in patients already on a regimen of aspirin and atorvastatin therapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>12714159</pmid><doi>10.1016/S0002-9149(03)00161-9</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2003-05, Vol.91 (9), p.1116-1119 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73221613 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors - therapeutic use Anticholesteremic Agents - therapeutic use Aspirin Aspirin - therapeutic use Atorvastatin Biphenyl Compounds - therapeutic use Cardiovascular disease Cholesterol, LDL - blood Coronary Disease - drug therapy Coronary Disease - immunology Drug Therapy, Combination Female Heptanoic Acids - therapeutic use Humans Interleukin-6 - blood Irbesartan Isoquinolines - therapeutic use Male Middle Aged Monocytes - metabolism Patients Platelet Aggregation Inhibitors - therapeutic use Pyrroles - therapeutic use Quinapril Tetrahydroisoquinolines Tetrazoles - therapeutic use |
| title | Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A07%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Usefulness%20of%20quinapril%20and%20irbesartan%20to%20improve%20the%20anti-inflammatory%20response%20of%20atorvastatin%20and%20aspirin%20in%20patients%20with%20coronary%20heart%20disease&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Lauten,%20Wright%20B&rft.date=2003-05-01&rft.volume=91&rft.issue=9&rft.spage=1116&rft.epage=1119&rft.pages=1116-1119&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(03)00161-9&rft_dat=%3Cproquest_cross%3E341843521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230371727&rft_id=info:pmid/12714159&rft_els_id=S0002914903001619&rfr_iscdi=true |